Chugai Pharmaceutical Co. Ltd. (CHGCY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chugai Pharmaceutical Co....

    OTC: CHGCY · Real-Time Price · USD
    23.80
    0.64 (2.76%)
    At close: Oct 03, 2025, 3:59 PM
    23.89
    0.40%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    Chugai Pharmaceutical Balance Sheet Statement

    Financials in JPY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 540.2B 458.67B 222.17B 267.75B
    Short-Term Investments
    		 456.14B 280.31B 280.94B 204.22B
    Long-Term Investments
    		 73.07B 1.25B -279.1B -201.82B
    Other Long-Term Assets
    		 n/a 124.31B 335.29B 246.49B
    Receivables
    		 334.26B 318.89B 512.54B 355.08B
    Inventory
    		 240.07B 273.48B 292.21B 208.84B
    Other Current Assets
    		 35.38B 13.24B 9.92B 10.47B
    Total Current Assets
    		 1,606B 1,366.4B 1,336.5B 1,063.7B
    Property-Plant & Equipment
    		 441.55B 420.7B 386.65B 352.11B
    Goodwill & Intangibles
    		 17.87B 19.86B 25.14B 21.97B
    Total Long-Term Assets
    		 602.33B 566.12B 533.22B 475.03B
    Total Assets
    		 2,208.4B 1,932.5B 1,869.8B 1,538.7B
    Account Payables
    		 65.35B 112.47B 209.84B 152.27B
    Deferred Revenue
    		 n/a n/a 79M 86M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 109.91B 124.14B 169.63B 134.1B
    Total Current Liabilities
    		 290.36B 288.22B 423.73B 327.42B
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 11.44B 12.27B 13.97B 15.64B
    Total Long-Term Liabilities
    		 16.52B 18.75B 21.64B 23.25B
    Total Liabilities
    		 306.87B 306.97B 445.37B 350.68B
    Total Debt
    		 10.9B 13.46B 14.11B 16.04B
    Book Value
    		 1,901.5B 1,625.6B 1,424.4B 1,188B
    Book Value Per Share
    		 577.81 493.96 433.00 361.29
    Common Stock
    		 73.2B 73.2B 73.2B 73.2B
    Retained Earnings
    		 1,746.9B 1,488.7B 1,293.4B 1,054B
    Comprehensive Income
    		 11.47B -5.71B -10.97B -7.46B
    Shareholders Equity
    		 1,901.5B 1,625.6B 1,424.4B 1,188B
    Total Investments
    		 456.14B 280.31B 1.84B 2.39B

    Add to Watchlist